Skip to main content

Sexual Dysfunction, Physiological

4
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
3 programs
2
1
CP-866,087Phase 21 trial
Vaginal Heat Wash-Out DevicePhase 11 trial
Vaginal Heat Wash-Out DevicePhase 11 trial
Active Trials
NCT00443248Completed64Est. Oct 2008
NCT00443027Completed12Est. Oct 2008
NCT00482664Completed84Est. Oct 2008
VIVUS
VIVUSCA - Campbell
1 program
1
Topical alprostadilPhase 21 trial
Active Trials
NCT00324948Completed300Est. Nov 2006
J3 Bioscience
J3 BioscienceUT - Salt Lake City
1 program
VR101 Lubricating Intravaginal RingN/A1 trial
Active Trials
NCT04288752Completed176Est. May 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerCP-866,087
VIVUSTopical alprostadil
PfizerVaginal Heat Wash-Out Device
PfizerVaginal Heat Wash-Out Device
J3 BioscienceVR101 Lubricating Intravaginal Ring

Clinical Trials (5)

Total enrollment: 636 patients across 5 trials

NCT00482664PfizerCP-866,087

The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.

Start: Jul 2007Est. completion: Oct 200884 patients
Phase 2Completed
NCT00324948VIVUSTopical alprostadil

Topical Alprostadil for Female Sexual Arousal Disorder

Start: Sep 2004Est. completion: Nov 2006300 patients
Phase 2Completed
NCT00443248PfizerVaginal Heat Wash-Out Device

Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)).

Start: Mar 2007Est. completion: Oct 200864 patients
Phase 1Completed
NCT00443027PfizerVaginal Heat Wash-Out Device

Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women.

Start: Mar 2007Est. completion: Oct 200812 patients
Phase 1Completed
NCT04288752J3 BioscienceVR101 Lubricating Intravaginal Ring

Efficacy of VR101 as a Personal Lubricant

Start: Feb 2020Est. completion: May 2020176 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.